Reducing the burden of diabetes: Managing cardiovascular disease

Diabetes/Metabolism Research and Reviews

Volumn 15, Issue 3, 1999, Pages 186-196

  Keen, Harry ^a   Clark, Charles ^b   Laakso, Markku ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Diabetic complications; Hyperglycemia; Macrovascular disease; Pathogenesis; Prevention

Indexed keywords

BLOOD CLOTTING FACTOR 7; FIBRINOGEN; LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SIMVASTATIN; VON WILLEBRAND FACTOR;

ARTERIAL PRESSURE; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL FUNCTION; DIABETES MELLITUS; DISEASE PREDISPOSITION; DYSLIPIDEMIA; EARLY DIAGNOSIS; ENDOTHELIUM CELL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RISK FACTOR; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

CARDIOVASCULAR DISEASES; CORONARY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS;

EID: 0032808438     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-7560(199905/06)15:3<186::AID-DMRR30>3.0.CO;2-5     Document Type: Article

References (27)

1. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham Study. JAMA 1979; 241: 2035-2038.
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D for the Multiple Risk Factor Intervention Trial Research Group. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-444.
3. Morrish NJ, Wang S-L, Fuller JH and the WHO Multinational Study Group. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia, in press.
4. Aronson D, Rayfield EJ, Chesebro JH. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 1997; 126: 296-306.
5. Beks PHJ, Mackay AJC, de Vries H, de Neeling JND, Bouter LM, Heine RJ. Carotid artery stenosis is related to blood glucose level in an elderly Caucasian population: the Hoorn Study. Diabetologia 1997; 40: 290-298.
6. McGill HC Jr, McMahan CA, Malcom GT, Oalmann MC, Strong JP. Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 1995; 15: 431-440.
7. Jensen-Urstad KJ, Reichard PG, Rosfors JS, Lindblad LEL, Jensen-Urstad MT. Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes 1996; 45: 1253-1257.
8. Standl E, Balletshofer B, Dahl B, et al. Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project. Diabetologia 1996; 39: 1540-1545.
9. Lowe LP, Liu K, Greenland P, Metzger BE, Dyer AR, Stamler J. Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. Diabetes Care 1997; 20: 163-169.
10. Moss SE, Klein R, Klein BEK, Meuer SM. The association of glycemia and cause-specific mortality in a diabetic population. Arch Intern Med 1994; 154: 2473-2479.
11. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995; 18: 258-268.
12. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994; 43: 960-967.
13. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): effects on mortality at 1 year. J Am Coll Cardiol 1995; 26: 57-65.
14. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
15. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
16. University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 1976; 25: 1129-1153.
17. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 1998; 317: 703-713.
18. Eastman R, Keen H. Cardiovascular disease impact on patients with diabetes: potential for prevention. Lancet 1997; 350 (Suppl 1): 1-32.
19. Gillum RF. The association of body fat distribution with hypertension, hypertensive heart disease, coronary heart disease, diabetes and cardiovascular risk factors in men and women aged 18-79 years. J Chronic Dis 1987; 40: 421-428.
20. Laakso M, Sarlund H, Salonen R, Suhonen M, Pyörälä K, Salonen JT. Asymptomatic atherosclerosis and insulin resistance. Atheroscler Thromb 1991; 11: 1068-1076.
21. Despres JP, Lamarch B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor for ischaemic heart disease. N Engl J Med 1996; 334: 952-957.
22. European Arterial Risk Group. A strategy for arterial risk assessment and management in type 2 (non-insulin dependent) diabetes mellitus. Diabet Med 1997; 14: 611-621.
23. Lehto S, Rönnemaa T, Haffner SM, Pyörälä K, Kallio V, Laakso M. Dyslipidaemia and hyperglycaemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 1997; 46: 1354-1359.
24. Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke 1996; 27: 63-68.
25. Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Risk factors predicting lower extremity amputations in patients with NIDDM. Diabetes Care 1997; 20: 614-620.
26. Pyörälä K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. Diabetes Care 1997; 20: 614-620.
27. Curb JD, Pressel SL, Cutler JA, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 1996; 276: 1886-1892.